Clinical Trial Update: A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial evaluating infliximab (Remicade) for Crohn's disease has completed, assessing its safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED